Pharmafile - Sales and Marketing
After receiving FDA approval in January 2023, Biogen/Eisai’s new Alzheimer’s disease Leqembi is expected to become a blockbuster, with a predicted $...
Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front and further conditional...
BioNTech and OncoC4 have entered a strategic collaboration for the co-development and commercialisation of a novel checkpoint antibody for multiple...
Sun Pharma has decided a settlement of $75m as part of a case surrounding various pharma companies fixing their prices.
Features
While the pharmaceutical spotlight has shined brightest for COVID-19 vaccines and treatments, the undertone of counterfeit medicines...
Appointments
Hamamatsu Photonics Announces Mr. Tadashi Maruno as Representative Director and President
Hamamatsu Photonics, a leading...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
Events
Friday, September 23, 2022 - Saturday, September 24, 2022
London, United Kingdom
Conference
After an innovative 2021 competition that saw our finalists...
